| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019974 Immunoglobulins; cell line |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019963 Antibodies, polypeptides and uses thereof |
| 01/24/2008 | US20080019961 Hedgehog signaling pathway antagonist cancer treatment |
| 01/24/2008 | US20080019948 Process for Producing Engineered Targeted T Cell and Medicine |
| 01/24/2008 | US20080019946 Integration-type low-dose radiation-inducible vector |
| 01/24/2008 | US20080019919 Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | DE60128472T2 Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln Combined tumor therapy on the basis of distamycin acryloylderivaten and alkylating agents |
| 01/24/2008 | DE102006033140A1 Aminoindazolharnstoffderivate Aminoindazolharnstoffderivate |
| 01/24/2008 | DE10121982B4 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation |
| 01/24/2008 | DE10047272B4 Verfahren zur Fusion von dendritischen Zellen mit erkrankten Gewebezellen, insbesondere Tumorzellen Methods for the fusion of dendritic cells with diseased tissue cells, particularly tumor cells |
| 01/24/2008 | CA2658976A1 Aminoindazolylurea derivatives |
| 01/24/2008 | CA2658633A1 Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 01/24/2008 | CA2658404A1 Selective antagonists of a2a adenosine receptors |
| 01/24/2008 | CA2658327A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | CA2658276A1 Antagonist antibody for the treatment of cancer |
| 01/24/2008 | CA2658100A1 High-molecular weight conjugate of combretastatins |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657260A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | CA2656883A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | CA2656807A1 Early detection and prognosis of colon cancers |
| 01/24/2008 | CA2655623A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | CA2655238A1 Milk ingredient enriched in polar lipids and uses thereof |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1881000A1 Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents |
| 01/23/2008 | EP1880993A1 Nitrogen-containing heterocyclic compound |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1880723A1 Combination of mTOR inhibitor and antifolate compound |
| 01/23/2008 | EP1879922A2 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 01/23/2008 | EP1879901A1 Pyrrolobenzodiazepines |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879894A1 Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 01/23/2008 | EP1879870A1 Antitumoral tetrahydro-pyrimidines |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/23/2008 | EP1879856A2 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 01/23/2008 | EP1879657A2 Use of compounds to enhance processivity of telomerase |
| 01/23/2008 | EP1879656A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879611A2 Insp163 polypeptides for the treatment or prevention of cancer and arthritis |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879600A2 Nanotubes as mitochondrial uncouplers |
| 01/23/2008 | EP1879588A2 Combination therapy |
| 01/23/2008 | EP1879587A2 Methods and compositions for treating or preventing cancer |
| 01/23/2008 | EP1879585A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 01/23/2008 | EP1879584A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 01/23/2008 | EP1879562A2 Phenol derivatives and their use to modulate pkb activity |
| 01/23/2008 | EP1879554A2 Compositions and methods using microspheres and non-ionic contrast agents |
| 01/23/2008 | EP1799679B1 N,n'-dithenylurea derivatives suitable as kinase inhibitors |
| 01/23/2008 | EP1732898B1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 01/23/2008 | EP1560832B1 Pyrimido 4,5-d pyrimidine derivatives with anticancer activity |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1210372B1 Human monoclonal antibodies to her2/neu |
| 01/23/2008 | EP1188057B1 Incorporation and applications of biomolecular interactions within a carrier |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111518A Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111517A Novel peptides which interact with anti-apoptotic members ofthe family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111509A Novel pyrimidine nucleoside compound or its salt |
| 01/23/2008 | CN101111505A 伊班膦酸盐多晶型物b Ibandronate polymorphs b |
| 01/23/2008 | CN101111504A 伊班膦酸盐多晶型物a Ibandronate a polymorph |
| 01/23/2008 | CN101111495A Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101111258A Emulsified composition for dilution and cancer vaccine composition |
| 01/23/2008 | CN101111248A Treatment for cancer |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111241A Antineoplastic preparation and the use of antineoplastic preparation |
| 01/23/2008 | CN101111240A Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperp |
| 01/23/2008 | CN101109003A Selenium germanium peptide anti-tumor liuliangye liquor |
| 01/23/2008 | CN101109002A Selenium germanium peptide tumor restraining wide mountain grape wine |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108872A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108867A 1-0-caffeoyl -6-0-(S)-caesalpinia sepiaria acyl group -Beta-D-glucopyranose and uses thereof |
| 01/23/2008 | CN101108859A Vinblastine compound, method of preparing the same and use in medicament thereof |
| 01/23/2008 | CN101108846A 4- fragrant amido quinazoline derivatives and method of manufacturing the same and application in pharmacy thereof |
| 01/23/2008 | CN101108840A Chirality anona squamosa L. lactone compound with conformation limitation structure and synthesizing method and use thereof |
| 01/23/2008 | CN101108832A Five member ring heterocyclic compound, process for producing the same and application thereof |
| 01/23/2008 | CN101108826A Method for normal-temperature high-pressure aconine extracting and formulated product thereof |
| 01/23/2008 | CN101108791A Substituted benzyl ethylene derivant and method of preparing the same and use thereof |
| 01/23/2008 | CN101108252A Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same |
| 01/23/2008 | CN101108250A Mono- and disaccharide derivatives |
| 01/23/2008 | CN101108245A Formulated product used for human tumour combined treatment and use thereof |
| 01/23/2008 | CN101108234A Traditional Chinese medicine composition treating megakaryocytic leukemia |
| 01/23/2008 | CN101108224A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108215A Traditional Chinese medicine composition for treating lympha tumour leukocythemia |
| 01/23/2008 | CN101108195A Medicament for curing tumour, improving immunity of organism and method of manufacturing the same |
| 01/23/2008 | CN101108168A Method of manufacturing fulvestrant sustained-release microspheres |
| 01/23/2008 | CN101108164A Bcg polyoses nucleic acid intralipid and its cryochem formulated product and use thereof |